Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Buy
+562
New +$192K 0.07% 99
2019
Q2
Sell
-10,691
Closed -$2.03M 70
2019
Q1
$2.03M Sell
10,691
-4,094
-28% -$782K 1.78% 28
2018
Q4
$2.88M Buy
14,785
+272
+2% +$53.1K 3.05% 11
2018
Q3
$3.01M Buy
14,513
+443
+3% +$87.3K 2.81% 12
2018
Q2
$2.6M Buy
14,070
+234
+2% +$41.4K 2.64% 15
2018
Q1
$2.36M Buy
13,836
+1,187
+9% +$218K 2.46% 20
2017
Q4
$2.2M Buy
+12,649
New +$2.24M 2.23% 27

Other funds holding AMGN

Monte Financial Group's AMGN Position: Q2 2026 in Review

Monte Financial Group opened a new position in Amgen (AMGN) in Q2 2026: 562 shares worth $216K. The stake represents 0.07% of the portfolio and ranks #99 among its holdings. This is a return to the name: Monte Financial Group previously reported a position in AMGN as recently as Q1 2019.

Monte Financial Group first reported a position in AMGN in Q4 2017 and has held it in 7 quarters since. The position peaked at $3.01M in Q3 2018. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Monte Financial Group held 562 shares of Amgen worth $216K as of Q2 2026.
  • Amgen was a new Monte Financial Group position in Q2 2026.
  • Amgen made up 0.07% of Monte Financial Group's portfolio in Q2 2026, its #99 holding.
  • Monte Financial Group first reported a position in Amgen in Q4 2017 and has held it in 7 quarters since.
  • Monte Financial Group's Amgen position peaked at $3.01M in Q3 2018.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Monte Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.